Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

Cited by (1,010)

Items 201–300 of 1,010

1. Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
   Laurence Zitvogel, Oliver Kepp, Laura Senovilla, Laurie Menger, Nathalie Chaput, Guido Kroemer · 2010 · Clinical Cancer Research
2. Immunological impact of cell death signaling driven by radiation on the tumor microenvironment
   Rodriguez-Ruiz, Maria Esperanza, Vitale, Ilio, Harrington, Kevin J., Melero, Ignacio, Galluzzi, Lorenzo · 2020 · Nature Immunology
3. Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
   Laetitia Aymeric, Lionel Apétoh, François Ghiringhelli, Antoine Tesnière, Isabelle Martins, Guido Kroemer, Mark John Smyth, Laurence Zitvogel · 2010 · Cancer Research
4. Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
   Wolf H. Fridman, Jérôme Galon, Franck Pagès, Éric Tartour, Catherine Sautès‐Fridman, Guido Kroemer · 2011 · Cancer Research
5. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
   Antonio Maria Grimaldi, Ester Simeone, Diana Giannarelli, Paolo Muto, Sara Falivene, Valentina Borzillo, Francesca Maria Giugliano, Fabio Sandomenico, Antonella Petrillo, Marcello Curvietto et al. · 2014 · OncoImmunology
6. The multifunctional protein HMGB1: 50 years of discovery
   Daolin Tang, Rui Kang, Herbert J. Zeh, Michael T. Lotze · 2023 · Nature reviews. Immunology
7. Molecular Mechanisms of Radiation-Induced Cancer Cell Death: A Primer
   Sia, Joseph, Szmyd, Radoslaw, Hau, Eric, Gee, Harriet E. · 2020 · Frontiers in Cell and Developmental Biology
8. Fractionated Radiation Therapy Stimulates Antitumor Immunity Mediated by Both Resident and Infiltrating Polyclonal T-cell Populations when Combined with PD-1 Blockade
   Simon J. Dovedi, Eleanor J. Cheadle, Amy L. Popple, Edmund Poon, Michelle Morrow, Ross A. Stewart, Erik C. Yusko, Catherine Miller Sanders, Marissa Vignali, Ryan Emerson et al. · 2017 · Clinical Cancer Research
9. Type I interferon response and innate immune sensing of cancer
   Fuertes, Mercedes B., Woo, Seng-Ryong, Burnett, Byron, Fu, Yang-Xin, Gajewski, Thomas F. · 2013 · Trends in Immunology
10. Current clinical trials testing the combination of immunotherapy with radiotherapy
    Josephine Kang, Sandra Demaria, Silvia Chiara Formenti · 2016 · Journal for ImmunoTherapy of Cancer
11. Exosomes Shuttle TREX1-Sensitive IFN-Stimulatory dsDNA from Irradiated Cancer Cells to DCs
    Julie M. Diamond, Claire Vanpouille‐Box, Sheila Spada, Nils-Petter Rudqvist, Jessica R. Chapman, Beatrix M. Ueberheide, Karsten A. Pilones, Yasmeen Sarfraz, Silvia Chiara Formenti, Sandra Demaria · 2018 · Cancer Immunology Research
12. HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
    James F. Curtin, Naiyou Liu, Marianela Candolfi, Weidong Xiong, Hikmat H. Assi, Kader Yagiz, Matthew R Edwards, Kathrin S. Michelsen, Kurt M. Kroeger, Chunyan Liu et al. · 2009 · PLoS Medicine
13. Radiotherapy: Changing the Game in Immunotherapy
    Sandra Demaria, C. Norman Coleman, Silvia Chiara Formenti · 2016 · Trends in cancer
14. Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
    Schiavoni, Giovanna, Sistigu, Antonella, Valentini, Mara, Mattei, Fabrizio, Sestili, Paola, Spadaro, Francesca, Sanchez, Massimo, Lorenzi, Silvia, D'Urso, Maria Teresa, Belardelli, Filippo et al. · 2011 · Cancer Research
15. Interferon gamma in cancer immunotherapy
    Ni, Ling, Lu, Jian · 2018 · Cancer Medicine
16. Tumor-induced perturbations of cytokines and immune cell networks
    Brett Burkholder, Ren-Yu Huang, Rob Burgess, Shuhong Luo, Valerie Sloane Jones, Wenji Zhang, Zongqiang Lv, Changyu Gao, Bao-Ling Wang, Yuming Zhang et al. · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
17. Adaptive immune resistance at the tumour site: mechanisms and therapeutic opportunities
    Tae Kon Kim, Esten N. Vandsemb, Roy S. Herbst, Lieping Chen · 2022 · Nature Reviews Drug Discovery
18. Metal Drugs and the Anticancer Immune Response
    Englinger, Bernhard, Pirker, Christine, Heffeter, Petra, Terenzi, Alessio, Kowol, Christian R., Keppler, Bernhard K., Berger, Walter · 2019 · Chemical Reviews
19. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer
    Nathaniel R. West, Katy Milne, Pauline T. Truong, Nicol A. Macpherson, Brad H. Nelson, Peter Hamilton Watson · 2011 · Breast Cancer Research
20. Tumor-associated macrophages: Effectors of angiogenesis and tumor progression
    Seth B. Coffelt, Russell Hughes, Claire E. Lewis · 2009 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
21. Molecular mechanisms of late apoptotic/necrotic cell clearance
    Ivan K. H. Poon, Mark D. Hulett, Christopher Richard Parish · 2009 · Cell Death and Differentiation
22. Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
    Rui Kuai, Wenmin Yuan, Sejin Son, Jutaek Nam, Yao Xu, Yuchen Fan, Anna A. Schwendeman, James Jaehyun Moon · 2018 · Science Advances
23. Targeting HMGB1 in inflammation
    Yang, Huan, Tracey, Kevin J. · 2010 · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
24. Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
    Hiroyuki Inoue, Kenzaburo Tani · 2013 · Cell Death and Differentiation
25. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation
    Bernd Krüger, Stefanie Krick, Navdeep K. Dhillon, Susan Lerner, Scott A. Ames, Jonathan S. Bromberg, Marvin Lin, Liron Walsh, John P. Vella, Michael Fischereder et al. · 2009 · Proceedings of the National Academy of Sciences
26. Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
    Chang Qing Yang, Bai-Rong Xia, Zhao-Cong Zhang, Yongjian Zhang, Ge Lou, Weilin Jin · 2020 · Frontiers in Immunology
27. Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
    Alberto Mantovani, Antonio Sica, Paola Allavena, Cecília Garlanda, Massimo Locati · 2009 · Human Immunology
28. Mouse models in oncoimmunology
    Laurence Zitvogel, Jonathan M. Pitt, Romain Daillère, Mark John Smyth, Guido Kroemer · 2016 · Nature reviews. Cancer
29. Prostate cancer as a model for tumour immunotherapy
    Charles G. Drake · 2010 · Nature reviews. Immunology
30. Chemotherapy Alters Monocyte Differentiation to Favor Generation of Cancer-Supporting M2 Macrophages in the Tumor Microenvironment
    Dijkgraaf, Eveline M., Heusinkveld, Moniek, Tummers, Bart, Vogelpoel, Lisa T.C., Goedemans, Renske, Jha, Veena, Nortier, Johan W.R., Welters, Marij J.P., Kroep, Judith R., van der Burg, Sjoerd H. · 2013 · Cancer Research
31. A dual role of p53 in the control of autophagy
    Ezgi Tasdemir, Maria Chiara Maiuri, Eugenia Morselli, Alfredo Criollo, Marcello D’Amelio, Mojgan Djavaheri‐Mergny, Francesco Cecconi, Nektarios Tavernarakis, Guido Kroemer · 2008 · Autophagy
32. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death
    Panaretakis, T, Joza, N, Modjtahedi, N, Tesniere, A, Vitale, I, Durchschlag, M, Fimia, G M, Kepp, O, Piacentini, M, Froehlich, K-U et al. · 2008 · Cell Death & Differentiation
33. Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
    Willem Joost Lesterhuis, Cornelis J.A. Punt, Stanleyson V. Hato, Dagmar Eleveld-Trancikova, Bas Jansen, Stefan Nierkens, Gerty Schreibelt, Annemiek J. de Boer, Carla M.L. van Herpen, Johannes H.A.M. Kaanders et al. · 2011 · Journal of Clinical Investigation
34. Drugging Membrane Protein Interactions
    Hang Hubert Yin, Aaron D. Flynn · 2016 · Annual Review of Biomedical Engineering
35. Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
    Kaiyuan Ni, Guangxu Lan, Christina Chan, Bryan Quigley, Kuangda Lu, Theint Aung, Nining Guo, Patrick J. La Rivière, Ralph R. Weichselbaum, Wenbin Lin · 2018 · Nature Communications
36. Nuclear sensing of breaks in mitochondrial DNA enhances immune surveillance
    Tigano, Marco, Vargas, Danielle C., Tremblay-Belzile, Samuel, Fu, Yi, Sfeir, Agnel · 2021 · Nature
37. Toll-like receptors in inflammatory bowel diseases: A decade later
    Elke Cario · 2010 · Inflammatory Bowel Diseases
38. Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy
    Yuting Ma, Laetitia Aymeric, Clara Locher, Stephen R. Mattarollo, Nicolas F. Delahaye, Pablo Pereira, Laurent Boucontet, Lionel Apétoh, François Ghiringhelli, Noëlia Casares et al. · 2011 · The Journal of Experimental Medicine
39. CTLA-4 blockade in tumor models: an overview of preclinical and translational research.
    Joseph F. Grosso, Maria Jure‐Kunkel · 2013 · Europe PMC (PubMed Central)
40. Cell death in pancreatic cancer: from pathogenesis to therapy
    Xin Chen, Herbert J. Zeh, Rui Kang, Guido Kroemer, Daolin Tang · 2021 · Nature Reviews Gastroenterology & Hepatology
41. Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
    Stephen R. Mattarollo, Sherene Loi, Helene Duret, Yuting Ma, Laurence Zitvogel, Mark John Smyth · 2011 · Cancer Research
42. Radiation as an immunological adjuvant: current evidence on dose and fractionation
    Sandra Demaria, Silvia Chiara Formenti · 2012 · Frontiers in Oncology
43. The Yin and Yang of Toll-like receptors in cancer
    Jean‐Philippe Pradère, Dianne H. Dapito, Robert F. Schwabe · 2013 · Oncogene
44. High‐mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair
    Marco Emilio Bianchi, Massimo P. Crippa, Angelo Andrea Manfredi, Rosanna Mezzapelle, Patrizia Querini Rovere, Emilie Vénéreau · 2017 · Immunological Reviews
45. Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy
    Minlin Jiang, Keyi Jia, Lei Wang, Wei Li, Bin Chen, Yu Liu, Hao Wang, Sha Zhao, Yayi He, Caicun Zhou · 2021 · Acta Pharmaceutica Sinica B
46. NADPH oxidase controls phagosomal pH and antigen cross-presentation in human dendritic cells
    Mantegazza, Adriana R., Savina, Ariel, Vermeulen, Mónica, Pérez, Laura, Geffner, Jorge, Hermine, Olivier, Rosenzweig, Sergio D., Faure, Florence, Amigorena, Sebastián · 2008 · Blood
47. Creating immune privilege: active local suppression that benefits friends, but protects foes
    Andrew L. Mellor, David H. Munn · 2007 · Nature reviews. Immunology
48. Immune escape as a fundamental trait of cancer: focus on IDO
    George C. Prendergast · 2008 · Oncogene
49. Oncolytic viruses as therapeutic cancer vaccines
    David L. Bartlett, Zuqiang Liu, Magesh Sathaiah, Roshni Ravindranathan, Zongbi Guo, Yukai He, Zong Sheng Guo · 2013 · Molecular Cancer
50. Cytokines in immunogenic cell death: Applications for cancer immunotherapy
    Anne Showalter, Arati Limaye, Jeremiah L. Oyer, Robert Y. Igarashi, Christina Kittipatarin, Alicja Joanna Copik, Annette R. Khaled · 2017 · Cytokine
51. Immune microenvironments in solid tumors: new targets for therapy
    Stephen Lawrence Shiao, Anusha-Preethi Ganesan, Hope S. Rugo, Lisa M. Coussens · 2011 · Genes & Development
52. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy
    Junjie Wu, David J. Waxman · 2018 · Cancer Letters
53. Gut microbiota modulate dendritic cell antigen presentation and radiotherapy-induced antitumor immune response
    Uribe-Herranz, Mireia, Rafail, Stavros, Beghi, Silvia, Gil-de-Gómez, Luis, Verginadis, Ioannis, Bittinger, Kyle, Pustylnikov, Sergey, Pierini, Stefano, Perales-Linares, Renzo, Blair, Ian A. et al. · 2019 · Journal of Clinical Investigation
54. Immunogenic effects of chemotherapy-induced tumor cell death
    Yi‐Jun Wang, Rochelle Fletcher, Jian Yu, Lin Zhang · 2018 · Genes & Diseases
55. PD-1 Blockade Boosts Radiofrequency Ablation–Elicited Adaptive Immune Responses against Tumor
    Liangrong Shi, Lujun Chen, Changping Wu, Yibei Zhu, Bin Xu, Xiao Wei Zheng, Mingfen Sun, Wen Wen, Xichao Dai, Min Yang et al. · 2016 · Clinical Cancer Research
56. Cell death-induced immunogenicity enhances chemoimmunotherapeutic response by converting immune-excluded into T-cell inflamed bladder tumors
    Fotis Nikolos, Kazukuni Hayashi, Xen Ping Hoi, Mark Ellie Alonzo, Qianxing Mo, Armine Kasabyan, Hideki Furuya, Jane Trepel, Dolores Di Vizio, Jlenia Guarnerio et al. · 2022 · Nature Communications
57. Autophagy and metastasis: another double-edged sword
    Candia M. Kenific, Andrew M. Thorburn, Jayanta Debnath · 2009 · Current Opinion in Cell Biology
58. Toll-Like Receptor Agonists in Cancer Therapy
    Sylvia Adams · 2009 · Immunotherapy
59. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials
    Maria Vittoria Dieci, Marie Christine Mathieu, Valentina Guarneri, PierFranco Conte, Suzette Delaloge, Fabrice André, Aïcha Goubar · 2015 · Annals of Oncology
60. Pathologic Complete Response to Neoadjuvant Chemotherapy of Breast Carcinoma Is Associated with the Disappearance of Tumor-Infiltrating Foxp3+ Regulatory T Cells
    Sylvain Ladoire, Laurent Arnould, Lionel Apétoh, Bruno P. Coudert, François Martin, Bruno Chauffert, P. Fumoleau, François Ghiringhelli · 2008 · Clinical Cancer Research
61. Natural and therapy-induced immunosurveillance in breast cancer
    Guido Kroemer, Laura Senovilla, Lorenzo Galluzzi, Fabrice André, Laurence Zitvogel · 2015 · Nature Medicine
62. Type I interferon-mediated tumor immunity and its role in immunotherapy
    Yu, Renren, Zhu, Bo, Chen, Degao · 2022 · Cellular and Molecular Life Sciences
63. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death
    Garg, Abhishek D., Dudek, Aleksandra M., Ferreira, Gabriela B., Verfaillie, Tom, Vandenabeele, Peter, Krysko, Dmitri V., Mathieu, Chantal, Agostinis, Patrizia · 2013 · Autophagy
64. Tumor-infiltrating lymphocytes are correlated with response to neoadjuvant chemotherapy in triple-negative breast cancer
    Makiko Ono, Hitoshi Tsuda, Chikako Shimizu, Sohei Yamamoto, Tatsuhiro Shibata, Harukaze Yamamoto, Taizo Hirata, Kan Yonemori, Masashi Ando, Kenji Tamura et al. · 2011 · Breast Cancer Research and Treatment
65. Immunogenic cancer cell death: a key-lock paradigm
    Antoine Tesnière, Lionel Apétoh, François Ghiringhelli, Nicholas A. Joza, Theocharis Panaretakis, Oliver Kepp, Frédéric Schlemmer, Laurence Zitvogel, Guido Kroemer · 2008 · Current Opinion in Immunology
66. The Role of TLRs in Anti-cancer Immunity and Tumor Rejection
    Zuzanna Urban‐Wójciuk, Mohd M. Khan, Benjamin L. Oyler, Robin Fåhræus, Natalia Maria Marek-Trzonkowska, Aleksandra Nita‐Lazar, Ted R. Hupp, David R. Goodlett · 2019 · Frontiers in Immunology
67. Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
    Sandra Demaria, Chandan Guha, Jonathan Daniel Schoenfeld, Zachary Scott Morris, Arta Monir Monjazeb, Andrew Gregory Sikora, Marka R. Crittenden, Stephen Lawrence Shiao, Samir N. Khleif, Seema Gupta et al. · 2021 · Journal for ImmunoTherapy of Cancer
68. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy
    Jonathan G. Pol, Erika Vacchelli, Fernando Aranda, Francesca Castoldi, Alexander M.M. Eggermont, Isabelle Cremer, Catherine Sautès‐Fridman, Jitka Palich Fucikova, Jérôme Galon, Radek Špíšek et al. · 2015 · OncoImmunology
69. The Role of the Microbiota in Inflammation, Carcinogenesis, and Cancer Therapy
    Dzutsev, Amiran, Goldszmid, Romina S., Viaud, Sophie, Zitvogel, Laurence, Trinchieri, Giorgio · 2015 · European Journal of Immunology
70. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design
    Antonella Sistigu, Sophie Viaud, Nathalie Chaput, Laura Bracci, Enrico Proietti, Laurence Zitvogel · 2011 · Seminars in Immunopathology
71. Oxidative Stress and Programmed Cell Death in Yeast
    Gianluca Farrugia, Rena Balzan · 2012 · Frontiers in Oncology
72. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy
    Davide Ciardiello, Pietro Paolo Vitiello, Claudia Cardone, Giulia Martini, Teresa Troiani, Erika Martinelli, Fortunato Ciardiello · 2019 · Cancer Treatment Reviews
73. Combined Radiotherapy and Anti–PD-L1 Antibody Synergistically Enhances Antitumor Effect in Non–Small Cell Lung Cancer
    Xiaomei Gong, Xuefei Li, Tao Jiang, Huikang Xie, Zhengfei Zhu, Fei Zhou, Caicun Zhou · 2017 · Journal of Thoracic Oncology
74. Selenium‐Containing Nanoparticles Combine the NK Cells Mediated Immunotherapy with Radiotherapy and Chemotherapy
    Shiqian Gao, Tianyu Li, Ye Guo, Chenxing Sun, Banruo Xianyu, Huaping Xu · 2020 · Advanced Materials
75. The role of dendritic cells in cancer and anti-tumor immunity
    Ariel E. E. Marciscano, Niroshana Anandasabapathy · 2021 · Seminars in Immunology
76. Cancer and the Immune System: Basic Concepts and Targets for Intervention
    Drew M. Pardoll · 2015 · Seminars in Oncology
77. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy
    Oliver Kepp, Lorenzo Galluzzi, Isabelle Martins, Frédéric Schlemmer, Sandy Adjemian, Mickaël Michaud, Abdul Qader Sukkurwala, Laurie Menger, Laurence Zitvogel, Guido Kroemer · 2011 · Cancer and Metastasis Reviews
78. Cross-Talk Between Antigen Presenting Cells and T Cells Impacts Intestinal Homeostasis, Bacterial Infections, and Tumorigenesis
    Stephen J. Gaudino, Pawan Kumar · 2019 · Frontiers in Immunology
79. Doxorubicin and other anthracyclines in cancers: Activity, chemoresistance and its overcoming
    Roberto Mattioli, Andrea Ilari, Beatrice Colotti, Luciana Mosca, Francesco Fazi, Gianni Colotti · 2023 · Molecular Aspects of Medicine
80. Metal-based anticancer agents as immunogenic cell death inducers: the past, present, and future
    Sen, Sajal, Won, Miae, Levine, Matthew S., Noh, Yuvin, Sedgwick, Adam C., Kim, Jong Seung, Sessler, Jonathan L., Arambula, Jonathan F. · 2022 · Chemical Society Reviews
81. CD40 stimulation obviates innate sensors and drives T cell immunity in cancer
    Byrne, Katelyn T., Vonderheide, Robert H. · 2016 · Cell Reports
82. Many faces of DAMPs in cancer therapy
    Olga Krysko, Tania Løve Aaes, Claus Bachert, Peter Vandenabeele, Dmitri V. Krysko · 2013 · Cell Death and Disease
83. Mechanisms of immune evasion in breast cancer
    Joshua P. Bates, Roshanak Derakhshandeh, Laundette P. Jones, Tonya J. Webb · 2018 · BMC Cancer
84. An ER‐Targeting Iridium(III) Complex That Induces Immunogenic Cell Death in Non‐Small‐Cell Lung Cancer
    Lili Wang, Ruilin Guan, Lina Xie, Xinxing Liao, Kai Xiong, Thomas W. Rees, Yu Chen, Liangnian Ji, Hui Chao · 2020 · Angewandte Chemie International Edition
85. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation
    Hulda Sigridur Hreggvidsdottir, Therese Östberg, Heidi Wähämaa, Hanna Schierbeck, Ann-Charlotte Aveberger, Lena Klevenvall, Karin Palmblad, Lars Ottosson, Ulf Andersson, Helena Erlandsson Harris · 2009 · Journal of Leukocyte Biology
86. DAMPs as mediators of sterile inflammation in aging-related pathologies
    Feldman, Noa, Rotter-Maskowitz, Aviva, Okun, Eitan · 2015 · Ageing Research Reviews
87. Tumor-specific GPX4 degradation enhances ferroptosis-initiated antitumor immune response in mouse models of pancreatic cancer
    Jingbo Li, Jiao Liu, Zhuan Zhou, Runliu Wu, Xin Chen, Chunhua Yu, Brent R. Stockwell, Guido Kroemer, Rui Kang, Daolin Tang · 2023 · Science Translational Medicine
88. Radiation and immunotherapy: a synergistic combination
    Anusha K. Kalbasi, Carl H. June, Naomi Balzer Haas, Neha Vapiwala · 2013 · Journal of Clinical Investigation
89. Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
    Victoria D. Turubanova, Балалаева Ирина Владимировна, Tatiana A. Mishchenko, Elena Catanzaro, Razan Alzeibak, Nina N. Peskova, Iuliia Efimova, Claus Bachert, Еlena V. Mitroshina, Olga Krysko et al. · 2019 · Journal for ImmunoTherapy of Cancer
90. DNAzyme Targeting c- jun Suppresses Skin Cancer Growth
    Hong Cai, Fernando S. Santiago, Leonel Prado-Lourenço, Bo Wang, Margaret Patrikakis, Miles P. Davenport, Ghassan J. Maghzal, Roland Stocker, Christopher Richard Parish, Beng H. Chong et al. · 2012 · Science Translational Medicine
91. The convergence of radiation and immunogenic cell death signaling pathways
    Encouse B. Golden, Ilenia Pellicciotta, Sandra Demaria, Mary Helen Barcellos‐Hoff, Silvia Chiara Formenti · 2012 · Frontiers in Oncology
92. Combining immunotherapy and anticancer agents: the right path to achieve cancer cure?
    Lionel Apétoh, Sylvain Ladoire, George Coukos, François Ghiringhelli · 2015 · Annals of Oncology
93. Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
    Lhuillier, Claire, Rudqvist, Nils-Petter, Elemento, Olivier, Formenti, Silvia C., Demaria, Sandra · 2019 · Genome Medicine
94. Chemotherapy induces ATP release from tumor cells
    Isabelle Martins, Antoine Tesnière, Oliver Kepp, Mickaël Michaud, Frédéric Schlemmer, Laura Senovilla, Claire Séror, Didier Métivier, Jean‐Luc Perfettini, Laurence Zitvogel et al. · 2009 · Cell Cycle
95. The genomic landscape of breast cancer and its interaction with host immunity
    Stephen James Luen, Balaji Virassamy, Peter Stephen Savas, Roberto Salgado, Sherene Loi · 2016 · The Breast
96. Lactate-Modulated Immunosuppression of Myeloid-Derived Suppressor Cells Contributes to the Radioresistance of Pancreatic Cancer
    Xuguang Yang, Yun Lu, Junjie Hang, Junfeng Zhang, Tiening Zhang, Yan‐Miao Huo, Jun Liu, Songtao Lai, Dawei Luo, Liwei Wang et al. · 2020 · Cancer Immunology Research
97. Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
    Thorburn, J, Horita, H, Redzic, J, Hansen, K, Frankel, A E, Thorburn, A · 2009 · Cell Death & Differentiation
98. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics
    Abhishek Dinkarnath Garg, Sanket More, Nicole Rufo, Odeta Meçe, Maria Livia Sassano, Patrizia Agostinis, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi · 2017 · OncoImmunology
99. Endogenous Damage-Associated Molecular Pattern Molecules at the Crossroads of Inflammation and Cancer
    Geetha Srikrishna, Hudson H. Freeze · 2009 · Neoplasia
100. Tipping the immunostimulatory and inhibitory DAMP balance to harness immunogenic cell death
     Kazukuni Hayashi, Fotis Nikolos, Y. C. Lee, Antrix Jain, Efrosini Tsouko, Hongbo Gao, Armine Kasabyan, Hon‐Chiu Eastwood Leung, Arsen Osipov, Sung Yun Jung et al. · 2020 · Nature Communications